Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Capital Expenditures (2016 - 2026)

Insight Molecular Diagnostics' Capital Expenditures history spans 6 years, with the latest figure at $1.5 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 591.12% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 517.25% increase, with the full-year FY2025 number at $3.2 million, up 517.25% from a year prior.
  • Capital Expenditures hit $1.5 million in Q4 2025 for Insight Molecular Diagnostics, up from $1.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for IMDX hit a ceiling of $1.6 million in Q1 2022 and a floor of -$564000.0 in Q3 2023.
  • Historically, Capital Expenditures has averaged $554888.9 across 5 years, with a median of $397500.0 in 2021.
  • Biggest five-year swings in Capital Expenditures: soared 1813.64% in 2021 and later crashed 165.66% in 2023.
  • Tracing IMDX's Capital Expenditures over 5 years: stood at $401000.0 in 2021, then skyrocketed by 100.0% to $802000.0 in 2022, then crashed by 67.08% to $264000.0 in 2023, then decreased by 18.94% to $214000.0 in 2024, then soared by 591.12% to $1.5 million in 2025.
  • Business Quant data shows Capital Expenditures for IMDX at $1.5 million in Q4 2025, $1.0 million in Q3 2025, and $349000.0 in Q2 2025.